Literature DB >> 22689569

Early pregnancy screening for hypertensive disorders in women without a-priori high risk.

A Abdelaziz1, M A Maher, T M Sayyed, M F Bazeed, N S Mohamed.   

Abstract

OBJECTIVES: To evaluate the performance of mean arterial pressure, uterine artery pulsatility index and soluble endoglin level alone or in combination in screening for hypertensive disorders in pregnant women without a-priori high risk.
METHODS: This was a nested case-control study of women with singleton pregnancies without a-priori high risk who developed pregnancy-induced hypertensive complications. Women were enrolled into the study at 11-14 weeks' gestation, when mean arterial pressure and uterine artery pulsatility index were recorded and a blood sample was taken for measurement of soluble endoglin. Women were followed up in the clinic to detect development of any hypertensive disorder. Each affected case was matched with two normotensive control women with uncomplicated pregnancies that resulted in phenotypically normal infants. Mean values for each variable were compared between cases and controls. Sensitivities, positive predictive values and negative predictive values at fixed specificity were derived from receiver-operating characteristics (ROC) curves.
RESULTS: During the study period, 2120 patients were examined. Of these, 170 (8.02%) were excluded because they were lost to follow-up and in 52 (2.45%) there was fetal death or miscarriage before 24 weeks' gestation. Thus, 1898 cases formed the cohort population. Of these, 89 (4.69%) patients developed complications (study group), including 16 (0.84%) cases with early pre-eclampsia (PE), 60 (3.16%) with late PE and 13 (0.68%) with gestational hypertension (GH). There were 49 (2.58%) cases of spontaneous preterm delivery before 34 weeks. The rest of the cohort population (1760 (92.73%) patients, the base cohort) were not affected by PE or GH. The control group comprised 178 patients. The best model for the prediction of any of the types of hypertensive disorders was one that combined mean arterial pressure with soluble endoglin (area under the ROC curve (AUC), 0.83). The predictive value of the three combined markers was highest for screening for early and late PE (AUC, 0.86 and 0.83, respectively). When each marker was considered alone, the highest prediction of any type of hypertensive disorder was achieved by mean arterial pressure (AUC, 0.73). Sensitivity was lowest for detection of GH when screening both by individual and by combined markers.
CONCLUSION: First-trimester screening can be useful in predicting women at high risk of developing hypertensive disorders of pregnancy but more prospective longitudinal studies are needed.
Copyright © 2012 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689569     DOI: 10.1002/uog.11205

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  6 in total

Review 1.  Endoglin in liver fibrogenesis: Bridging basic science and clinical practice.

Authors:  Steffen K Meurer; Muhammad Alsamman; David Scholten; Ralf Weiskirchen
Journal:  World J Biol Chem       Date:  2014-05-26

2.  ELABELA plasma concentrations are increased in women with late-onset preeclampsia.

Authors:  Bogdan Panaitescu; Roberto Romero; Nardhy Gomez-Lopez; Percy Pacora; Offer Erez; Felipe Vadillo-Ortega; Lami Yeo; Sonia S Hassan; Chaur-Dong Hsu
Journal:  J Matern Fetal Neonatal Med       Date:  2018-07-22

3.  TRAIL Is Decreased Before 20 Weeks Gestation in Women with Hypertensive Disorders of Pregnancy.

Authors:  Cheng Zhou; Yan Long; Hongling Yang; Chunyan Zhu; Qingling Ma; Yonggang Zhang
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

4.  The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study.

Authors:  Offer Erez; Roberto Romero; Eli Maymon; Piya Chaemsaithong; Bogdan Done; Percy Pacora; Bogdan Panaitescu; Tinnakorn Chaiworapongsa; Sonia S Hassan; Adi L Tarca
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

5.  Diagnostic Value of IGFBP-2 in Predicting Preeclampsia before 20 Weeks of Pregnancy: A Prospective Nested Case-Control Study.

Authors:  Fei Gao; Jiaye Yin; Yan Long; Sufei Zhu; Zhenting Huang; Jielin Wang; Hao Zheng; Wen Wang; Lei Zheng
Journal:  Comput Math Methods Med       Date:  2022-09-28       Impact factor: 2.809

6.  Identification of High-Risk Pregnancies in a Remote Setting Using Ambulatory Blood Pressure: The MINDI Cohort.

Authors:  Doris González-Fernández; Emérita Del Carmen Pons; Delfina Rueda; Odalis Teresa Sinisterra; Enrique Murillo; Marilyn E Scott; Kristine G Koski
Journal:  Front Public Health       Date:  2020-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.